Our mission at McNeil is to make a difference in the world by delivering the most sought after healthcare solutions, creating an unparalleled experience to consumers, retailers, healthcare professionals and the others that we serve.
Our vision for the future is to create better lives through better health.
McNeil is founded when Robert McNeil opens McNeil Pharmacy in Philadelphia, where he manufactures and sells medications to hospitals and doctors throughout the city.
Robert McNeil's son, Robert Lincoln McNeil, begins his fifty-year management career at McNeil, focusing much of the company's development on the expanding pharmaceutical market.
McNeil Pharmacy is incorporated as McNeil Laboratories, specializing in the direct marketing of prescription pharmaceuticals to doctors, pharmacists and hospitals.
McNeil introduces TYLENOL® Elixir for children, the first aspirin-free pain reliever. TYLENOL® Elixir is available by prescription only.
Johnson & Johnson acquires McNeil Laboratories, at the time net sales were $11.4 million and sales force numbered 225. The following year, TYLENOL® is approved for sale without a prescription.
As the TYLENOL® line of over-the-counter (OTC) options grows (including the launch of Adult TYLENOL® Regular Strength), so does McNeil. The company moves into its Fort Washington Headquarters.
The TYLENOL® line of products becomes the 5th best-selling brand of analgesic in the U.S. - Johnson & Johnson responds by creating the McNeil Consumer Products Division to manage its rapidly expanding OTC business.
As McNeil launches TYLENOL® Extra Strength tablets, the TYLENOL® line of products becomes the #1 branded OTC analgesic in the U.S.
McNeil Laboratories divides into two separate organizations; McNeil Pharmaceutical, a prescription only drug company, and McNeil Consumer Products Company, responsible for all OTC products marketed directly to consumers and health care professionals.
TYLENOL® becomes the #1 branded product in the Health and Beauty Aid category, surpassing the 18-year leader, CREST® toothpaste.
McNeil launches the first safety sealed tamper-resistant packaging in response to a criminal tampering incident with Extra Strength TYLENOL®.
McNeil launches Extra Strength TYLENOL® Gelcaps, a new innovative dosing form that is easy-to-swallow.
McNeil continues to expand the TYLENOL® line of products, including TYLENOL® Arthritis Pain, TYLENOL® PM and TYLENOL® cold products. During this time McNeil also acquired MOTRIN® and launched Children's MOTRIN®.
McNeil launches TYLENOL® Extra Strength Rapid Release Gels, which are Gelcaps that are specially designed with holes to allow the release of powerful medicine even faster than before.
Through the acquisition of Pfizer Consumer Healthcare by Johnson & Johnson McNeil acquires BENADRYL®, SUDAFED® and ZYRTEC®. The following year McNeil launches ZYRTEC® OTC, which was previously prescription only.
McNeil launches TYLENOL® PM Rapid Release Gels, which relieve your pain fast so you can sleep and feel refreshed after a good night's rest.
McNeil launches PRECISE™, the first ever external pain reliever from the Makers of TYLENOL®.
McNeil Consumer Healthcare contines to seek new opportunities to bring our products to consumers around the world, creating better lives through better health.